Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
Podcast - Inside Telehealth's Growth, Regulation and Access
Health-e Law Podcast, Episode 25 | Human-in-the-Loop: Bringing AI to Skilled Nursing Facilities
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo-Immuno Tech & MUSC
False Claims Act Insights - Healthcare Compensation and Referrals: Avoiding Compliance Pitfalls in Physician Deals
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
Hospice Insights Podcast - High Risk Hospices Are in the Hot Seat Across Six States
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen
PODCAST – 2026 To Do: HIPAA Compliance
2026 To Do: HIPAA Compliance
Health-E Law Podcast, Episode 24 | ViVE 2026: AI and the Future of Healthcare
Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature....more
What is the West Coast Health Care Fraud Strike Force? - DOJ’s Fraud Division announced the West Coast Health Care Fraud Strike Force on April 30, 2026, as a multidistrict enforcement initiative uniting the Division’s...more
Skin substitutes, bioengineered or natural materials designed to promote healing by replacing or supporting damaged skin, have become a key component of advanced wound care....more
Mako Capital Group has announced its launch. Mako, based in Miami, is a private equity firm specializing in acquiring lower-middle market U.S. companies in healthcare, financial and other services. Mako targets...more
The U.S. Food and Drug Administration’s (FDA) Office of Dietary Supplement Programs (ODSP) recently held a public meeting to solicit input from stakeholders on how the Agency should regulate modern dietary ingredient...more
We spend a lot of time with manufacturing leaders, quality teams, and in-house counsel who are all talking about the same basic issue, just from different angles: automation, AI, data, and how far to push “digital...more
This first installment of our overview of regulations finalized in 2025 summarizes recently adopted rules and amendments affecting healthcare providers, long-term care facilities, residential operators, and licensed...more
As healthcare organizations increasingly embrace artificial intelligence (AI)—moving from common use cases in ambient dictation and revenue cycle management, to wide scale adoption across sectors—it brings increased legal,...more
This article outlines key questions and compliance concepts to consider based on common scenarios in which healthcare entities “feed the machine” with sensitive data. Explore all articles in our AI in Healthcare series. Key...more
FDA announced version 4.0 of Elsa, its internal AI chatbot for staff, and a new internal data platform called Harmonized AI & Lifecycle Operations for Data (“HALO”), which consolidates “more than 40 disparate application and...more
AI is rapidly being integrated into healthcare delivery, operations, and patient engagement, increasing legal and compliance complexity. This checklist highlights key risks and considerations across data use, contracting,...more
The U.S. Department of Health and Human Services Office of Inspector General (“OIG”) recently updated its General Questions Regarding Certain Fraud and Abuse Authorities FAQ page—a resource which offers the healthcare...more
The United States Department of Health and Human Services (HHS) provides a helpful set of questions and answers on its website regarding the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Professionals...more
This article highlights key legal considerations for using AI systems with protected health information (PHI), with a focus on agreements, business associate obligations, and data governance. Explore all articles in our AI in...more
In a trio of recent website tracking decisions, the District of Massachusetts resolved motions to dismiss privacy claims related to third-party tracking technologies on healthcare websites: Progin v. UMass Memorial Health...more
On May 1, the US Food and Drug Administration (FDA) announced that it is proposing to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List. If finalized, this proposal would close the last remaining...more
On April 30, 2026, USCIS updated its Screening and Vetting guidance page to add "applications associated with medical physicians" to the group of cases eligible for its internal hold-lift review process, a notable development...more
On May 6, 2026, the Food and Drug Administration (“FDA” or “the Agency”) issued a press release officially announcing a pilot program for one-day inspectional assessments. According to the press release, FDA quietly started...more
FDA announced on March 11, 2026 the launch of the Adverse Event Monitoring System (AEMS), a modernized database designed to centralize and streamline the analysis and publication of adverse event reports for all FDA-regulated...more
Part 1 of this series focused on diligence and opinions. Patent prosecution is undergoing the same transition: AI has dramatically improved efficiency, but strategic value increasingly comes from understanding where...more
Key Takeaways - OIG’s new FAQ #17 reiterates that fair market value alone does not eliminate risk under the Federal Anti-Kickback Statute and emphasizes that AKS compliance depends on the full facts and circumstances,...more
Our Health Care Group investigates a lawsuit against Character.AI that raises legal risks for AI platforms presenting themselves as licensed professionals and signals tightening regulatory scrutiny....more
Hosts Heather and Lauren are joined by Leslie Isenhour, Dean of Biotechnologies and North Carolina BioNetwork Capstone Center at Wake Tech Community College. With the growing demand for life sciences talent in North Carolina,...more
The United States Departments of Labor, Health and Human Services, and the Treasury (collectively, the Departments) recently issued the 2025 MHPAEA Report to Congress (the Report), summarizing enforcement activity related to...more
Congress returns from a one-week recess, with most focus on advancing reconciliation 2.0. Before leaving for recess, House Republicans passed the reconciliation 2.0 budget resolution, and the Senate this week will begin...more
